Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2006 2
2007 4
2008 2
2009 2
2010 3
2011 5
2012 3
2013 3
2015 3
2016 1
2017 2
2018 3
2019 3
2020 2
2021 4
Text availability
Article attribute
Article type
Publication date

Search Results

36 results
Results by year
Filters applied: . Clear all
Page 1
Advances in the development of hybrid anticancer drugs.
Fortin S, Bérubé G. Fortin S, et al. Expert Opin Drug Discov. 2013 Aug;8(8):1029-47. doi: 10.1517/17460441.2013.798296. Epub 2013 May 7. Expert Opin Drug Discov. 2013. PMID: 23646979 Review.
Evaluation of the time-dependent antiproliferative activity and liver microsome stability of 3 phenyl 4-(2-oxo-3-alkylimidazolidin-1-yl)benzenesulfonates as promising CYP1A1-dependent antimicrotubule prodrugs.
Zarifi Khosroshahi M, Corin Chavez Alvarez A, Gagné-Boulet M, C-Gaudreault R, Gobeil S, Fortin S. Zarifi Khosroshahi M, et al. Among authors: fortin s. J Pharm Pharmacol. 2020 Feb;72(2):249-258. doi: 10.1111/jphp.13198. Epub 2019 Nov 14. J Pharm Pharmacol. 2020. PMID: 31729035
36 results